NEUTRON CRYSTALLOGRAPHY OF BIOLOGICAL MOLECULES

 

E. Buchtelová

Department of Biochemistry, Faculty of Science, Charles University, 128 43 Prague, Czech Republic

 

 

Advantages of neutron diffraction - why to use neutrons

 

Neutron diffraction is used much less than X-ray diffraction for protein structure determination. This is because the flux of neutron beams is much lower than the flux of X-ray beams, and also because of low availability of neutron sources. Nevertheless some problems can be solved only by diffraction of neutrons [1]. The main advantage of neutrons is their relatively high elastic scattering by hydrogen. Hydrogen atoms can be seen in maps obtained with neutrons even if they are not visible with X-rays. Neutron diffraction is therefore used to determine the positions of important hydrogen atoms, such as atoms involved in enzymatic reactions or in important hydrogen bonds and to study hydratation of biomolecules. Neutron diffraction can tell us whether a particular acidic group is dissociated or has a hydrogen atom bound to it, it can discriminate between water and hydroxyl anion in the active site of an enzyme, it can determine the orientation of a water molecule. Even if only low resolution data can be obtained, neutron diffraction can give us information on the position of solvent or other hydrogen containing molecule. In such cases labelling of the molecule of interest by replacing its hydrogen atoms by deuterium is used.

In contrast to X-rays, neutrons are not scattered by electrons but by the nuclei of atoms in biological materials. The interactions of neutrons with nuclei depend on strong nuclear forces and the scattering amplitudes vary from element to element in a non systematic way, which means atoms of similar atomic mass can be distinguished which would seem the same with X-rays. Even different isotopes or nuclei with different spin have different scattering amplitudes.

 The scattering amplitude of hydrogen is of the same order of magnitude as the amplitudes of other atoms predominating in biological molecules (Table 1.), so the scattering by hydrogen is not overridden by heavier atoms. The scattering from hydrogen can be increased even more by replacing hydrogen H11 by deuterium (H12, often written as D). The deuterium amplitude is almost twice as high as that of hydrogen H11. Moreover incoherent scattering, which creates background in the diffraction image, is lower for deuterium than for hydrogen. The deuterium amplitude is positive, while the hydrogen H11 amplitude is negative. When hydrogen atom is bound to a heavier atom, the neighbouring positive and negative densities can partially cancel out. This does not happen with deuterium. The difference between hydrogen and deuterium scattering can be used for labelling only some atoms and/or computing difference in maps from data obtained with hydrogen only and from data with deuterated molecule(s). By comparison of the maps the position of the deuterated molecule can be assigned to a peak in positive difference map even if the resolution is too low to recognise it from the shape of the peak.

 

Table 1. Coherent neutron scattering amplitudes [2].

 

 

Element or isotope

H

D

C

N

O

Coherent neutron scattering length bcoh (10-15m)

-3.7

6.7

6.6

9.4

5.8

 

 

The easiest and cheapest way to partially deuterate the crystal is to incubate it in D2O. Protein crystals have a large content of solvent H2O, which will be replaced by D2O, and some of the hydrogen atoms of the protein or other biomolecule will exchange with the deuterium of the solvent. If we want to obtain a completely deuterated biomolecule, we have to grow the cells in which the biomolecules are synthesised in D2O and supply them with  deuterated food. That is much more expensive.

By using different ratios of H2O to D2O for the solvent it is possible to enhance contribution of specific parts of the crystal (for example detergent, lipids, nucleic acids or deuterated protein) to the scattering at low resolution and so to determine at very low resolution even the structure of disordered parts of the crystal.

 

 

 

Disadvantages of neutron diffraction - experimental limitations

 

The main disadvantage of neutrons is the low flux of the beam. At the LADI (Laue diffractometer) experimental station at ILL, the largest existing neutron beam source, the flux of partially monochromatised beam (l = 3.5 Å; dl/l = 20%) is 3 x 107 neutrons.cm-2.s-1, which is about ten orders of magnitude lower than the flux of monochromatised beams from whigler sources on synchrotrons. The strategy of using a partially monochromatised beam and quasi-Laue difraction pattern for structure determination was adopted at the LADI experimental station in order to decrease data collection time. Even so the data collection takes at least two weeks compared to less than hour at the synchrotrons with the highest flux.  

Because of the low flux and low interaction of neutrons with the sample large samples are necessary. The smallest protein crystals usable at present for neutron diffraction have to have volume 1 mm3. The crystals diffract to about 1 Å lower resolution than they do with X-rays. If the purpose of the experiment is to see the hydrogen atoms, the lowest resolution which gives acceptable results is around 2.8 Å, so only reasonably well ordered crystals can be used. Large size of molecule also hinders the experiments - the molecular weight of the largest protein for which data have been collected at LADI was 50 000 Da.

 

 

 

Description of the LADI experimental station at ILL

 

The LADI experimental station is mainly used for single-crystal studies of proteins at medium or high resolution [3]. It uses cold neutrons (neutrons with long wavelength). The long wavelengths, around 3.5 Å, have been selected to increase the scattered intensities. As mentioned before, a broad bandwidth of wavelengths is used combined with quasi-Laue structure determination. A still image is taken and than the crystal is rotated to the next position (for example by 8°) to cover the whole reciprocal space. A detector based on the image plate technology has been designed for this experimental station. It has been adapted for detection of neutrons by incorporating of Gd2O3 into the image plate. When hit by a neutron, Gd emits X-rays, which are then detected in the image plate in the normal way, first being absorbed by the colour centres to form a latent image, which is then read out by exposure to visible laser radiation. The detector is cylindrical, the sample being placed in the centre of the detector. Thus reflections diffracted to high angles can be recorded, which is necessary with the long wavelengths that are used. The resolution limit of the detector using the above mentioned wavelengths is around 1.5 Å. For the crystals that have been measured so far this limit was sufficient - none of them, with the exception of test lysozyme, diffracted to such a high resolution. For crystals with larger unit cell spatial overlaps can be a problem. This can be solved by decreasing the range of wavelengths to which the crystal is exposed and by decreasing the angle of rotation of the crystal at the same time. For extremely large unit cells (viruses) a planar detector perpendicular to the beam is also available.

The sample is usually placed in a capillary and measured at room temperature. Neutrons do not cause radiation damage of the protein crystal. If lower temperatures are of advantage, for example for decreasing the temperature factors of the solvent, cooling by liquid helium can also be used.

For data treatment software based on CCP4 Laue suit is used [4]. The indexing of the diffraction pattern takes advantage of the fact that cell parameters are already approximately known from diffraction experiments with X-rays. The main problem in data treatment is normalisation of the data for spectral distribution of the neutron beam, that is, reflections have to be scaled according to the intensity of the part of the source beam with wavelength that fulfilled diffraction conditions.

Once appropriate intensities have been assigned to the reflections, structure determination proceeds as is usual in X-ray protein crystallography, with the exception that neutron scattering amplitudes are used instead of X-ray scattering factors.

 

 

 

Examples of usage of neutrons in biocrystallography

 

The structure of aspartic protease endothiapepsin complexed with an inhibitor was determined by Laue diffraction study at LADI experimental station at 2.1 Å resolution [5]. The protonation state of catalytic aspartates was determined: Asp 215 was found to be protonated and Asp 32 was not protonated.

The neutron structure of hen egg white lysozyme at pH 7.0 determined to 2.0 Å resolution at LADI experimental station showed that neither of the catalytic residues Glu 35 and Asp 52 was protonated at pH 7.0, while earlier neutron studies had shown that Glu 35 is protonated at pH 5.0 [6].

The position of deuterium atoms of the bound water in concanavalin A was determined at 2.4 Å resolution by Laue diffraction. The authors were mainly interested in water bound in the saccharide binding site and in the metal binding site [7].

The hydrogen bonding network of cellulose II was determined by neutron fibre diffraction [8].

            The hydratation of DNA in A conformation was determined by neutron fiber diffraction [9]. Two chains of water were found in major groove, one chain linked the oxygen atoms of the phosphate backbone and a water feature was found in the centre of the molecule which was not resolved in the direction of the axis of DNA and which is supposed to be sequence-dependent.

 

[1] E. Pebay-Peyroula & D. Myles: Neutron crystallography of biological molecules. In: Structure and Dynamics of Biomolecules: Neutron and Synchrotron Radiation for Condensed Matter Studies, HERCULES volume IV, Oxford University Press, 2000.

[2] R. Scherm, Ann. Phys., 7 (1972) 349-370.

[3] http://www.ill.fr/YellowBook/LADI/

[4] http://www.ill.fr/YellowBook/LADI/ladimanual/Lmain.html

[5] L. Coates, P.T. Erskine, S.P. Wood, D.A. Myles & J.B. Cooper, Biochemistry, 40 (2001) 13149-13157.

[6] N. Niimura, Y. Minezaki, T. Nonaka, J.C. Castagna, F. Cipriani, P. Hoghoj, M.S. Lehmann & C. Wilkinson, Nature Struct. Biol., 4, 909-917.

[7] J. Habash, J. Raftery, R. Nuttall, H. J. Price, C. Wilkinson, A.J. Kalb (Gilboa) & J.R. Helliwell, Acta Cryst. D, 56 (2000) 541-550.

[8] P. Langan, Y. Nishiyama & H. Chanzy, J. Am. Chem. Soc., 121 (1999) 9940-9946.

[9] M.W. Shotton, L.H. Pope, T. Forsyth, P. Langan, R.C. Denny, U. Giesen, M.T. Dauvergne, & W. Fuller, Biophys Chem., 69 (1997) 85-96.